News from array biopharma inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

08:00 ET
Array BioPharma.

Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015. Ron...

Jul 27, 2015, 13:49 ET
Array BioPharma.

Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 On August 3, 2015

 Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the fourth quarter and full year of fiscal 2015 and hold a...

Jul 22, 2015, 02:01 ET
Array BioPharma.

AstraZeneca Provides Update On Selumetinib In Uveal Melanoma

 AstraZeneca today announced that the Phase 3 SUMIT study of selumetinib in combination with dacarbazine for the treatment of patients with...

Jul 06, 2015, 17:13 ET
Array BioPharma

Array BioPharma To Present At The Cantor Fitzgerald 2015 Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2015...

Jul 06, 2015, 08:00 ET
Array BioPharma.

Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients

Array BioPharma's (NASDAQ:  ARRY) wholly-owned RAF inhibitor, encorafenib, was showcased this past weekend at the 2015 ESMO World Congress of...

Jun 01, 2015, 09:00 ET
Array BioPharma

Binimetinib And Encorafenib Combination Shows Promising Clinical Activity And Potential Differentiated Safety In BRAF-Mutant Melanoma

Array BioPharma's (NASDAQ: ARRY) wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib, were showcased at the 2015 annual...

May 28, 2015, 09:00 ET
Array BioPharma

Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting

 Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the...

May 26, 2015, 09:00 ET
Array BioPharma.

Array BioPharma To Present At The Jefferies 2015 Global Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Jefferies 2015 Global...

May 07, 2015, 09:00 ET
Array BioPharma.

Array BioPharma To Present At The Bank Of America Merrill Lynch Healthcare Conference And The UBS Global Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill...

May 04, 2015, 07:00 ET
Array BioPharma.

Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2015

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the third quarter of its fiscal year ending June 30, 2015. Ron Squarer, Chief...

Apr 27, 2015, 17:31 ET
Array BioPharma

Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2015 On May 4, 2015

Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2015 and hold a conference call to discuss...

Mar 02, 2015, 08:00 ET
Array BioPharma.

Array Announces Completion Of Binimetinib And Encorafenib Transactions

Following announcements from both Novartis and GlaxoSmithKline regarding close of their transactions, Array BioPharma Inc. (NASDAQ: ARRY)...

Feb 25, 2015, 09:00 ET
Array BioPharma.

Array BioPharma To Present At The Cowen and Company Annual Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual...

Feb 05, 2015, 12:30 ET
LA02195LOGO

Array BioPharma To Present At The Leerink Swann Global Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Swann...

Feb 03, 2015, 08:00 ET
Jan 26, 2015, 15:00 ET
Array BioPharma.

Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2015 On February 3, 2015

 Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the second quarter of fiscal 2015 and hold a conference call to...

Jan 23, 2015, 08:00 ET
Array BioPharma.

Array Announces Agreement To Acquire ENCORAFENIB (LGX818)

 Array BioPharma Inc. (NASDAQ: ARRY) today announced that it has reached a definitive agreement with Novartis Pharma AG to acquire...

Jan 08, 2015, 14:00 ET
Array BioPharma.

Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan...

Dec 03, 2014, 16:01 ET
Array BioPharma.

Array To Regain Worldwide Rights To Binimetinib

 Array BioPharma Inc. (NASDAQ: ARRY) today announced that it has reached a definitive agreement with Novartis International Pharmaceutical Ltd....

Nov 25, 2014, 14:00 ET
Array BioPharma

Array BioPharma To Present At The Piper Jaffray And Oppenheimer 2014 Healthcare Conferences

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming...